Abstract
Second-generation drug-eluting stents (DES) have demonstrated superiority over first-generation DES with respect to reduction in MACE and target lesion revascularization (TLR). The aim of this study was to compare the clinical presentation, lesion characteristics, and outcomes of first-generation
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have